Specialized testing
Delivering value beyond the test result
Our commitment to improving patient outcomes propels the development of clinically impactful, patient-focused testing. Supported by clinical physicians and laboratory scientists with unmatched experience and expertise, our assays — several of which are unavailable elsewhere — deliver actionable answers that improve patient lives.
Our data-driven, evidence-based tests provide actionable answers for patients that clarify each patient’s unique healthcare journey.
Specialty testing menu
Collaborations that power innovation
We relentlessly innovate on behalf of patients to build tests of the future to help physicians impact more lives. Mayo Clinic Laboratories scientists and physicians are leaders in their fields and at the forefront of translating new ideas into meaningful solutions. Through groundbreaking collaborations with healthcare companies and diagnostics leaders, we simplify access to new and advanced laboratory tests.
Commitment to education
The exchange of knowledge is a founding principle at Mayo Clinic. In this tradition, we provide a wide range of education offerings and outreach consultation to help you drive continual improvement.
- Regionally based clinical specialists help guide best practices through physician education.
- Access to Mayo Clinic Laboratories' education offerings and Insight articles.
- Many courses offer CME credits.
- Online trainings are available, such as “Dangerous Goods Shipping,” and include printable certificates.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
We want to make you aware of a temporary disruption at the FedEx hub in Memphis, Tennessee, due to a chemical spill, which is affecting some inbound and outbound shipments.
In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Wendy Daigle and Ellen Dijkman Dulkes to explore the diverse roles and responsibilities of outreach leaders. Together, they share insights based on their own experiences and the work they do with clients.
This month’s microlearning breaks down what cryoprecipitate is and when it’s used.
A significant nor'easter named Hernando is impacting the Northeastern United States. The storm is producing blizzard conditions and heavy snowfall along coastal areas from Delaware through Maine and into eastern Canada. Mayo Clinic Laboratories' Global Logistics team is monitoring the situation and will advise as conditions improve.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how collaborations are helping drive transformation in clinical diagnostics.
Discover how to create an approach to innovation that drive innovation with meaningful healthcare advancements.
Discover seven steps for creating outreach roles to address service gaps, prevent burnout, and foster organizational growth.
We regret to inform you that the 11th Annual Forensic Science Symposium has been canceled due to low registration. This was an extremely difficult decision, and we understand this news may be disappointing.
As 2026 begins, Dr. Bill Morice shares his thoughts on the forces that will shape opportunities and challenges for the diagnostics industry this year.
This presentation offers a clear introduction to emerging blood based biomarkers for Alzheimer’s disease.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and celebrate an exciting milestone for Dr. Pritt’s “Creepy Dreadful Wonderful Parasites” blog.
We’ve created two new oral fluid specimen collection videos for controlled substance monitoring. The first video is designed to support healthcare professionals by outlining how to safely and effectively oversee a patient’s specimen collection. The second is from the patient’s perspective, giving them a step-by-step guide for what to expect during the collection process.